Questions discussed in this category
How do you incorporate PD-L1 blockade?
Do you repeat the loading dose of trastuzumab?
For example, in a patient > 70 years old?
Is there any evidence to use trastuzumab and pertuzumab without doxorubicin?
How does it vary for patients with a history of hypertension, diabetes, CHF, and coronary artery disease?
103607980653440673540334631443125
Papers discussed in this category
Cochrane Database Syst Rev, 2008 Apr 16
Eur. J. Cancer, 2013 May 22
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-09-01
The Lancet. Oncology, 2013-10
N. Engl. J. Med., 2017-07-13
The Lancet. Oncology, 2017-08
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-03-10
The Lancet. Oncology, 2019-06